Yuyu Pharma, Inc.
Financials
Valuation Metrics
Yuyu Pharma, Inc.'s Market Cap is ₩671B. At end of 2025 it was ₩865B. Ranked #1491 of 2,436 in KR market (top 61%), #640 of 787 on KOSPI (top 81%), #165 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 71%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 67.12B KRW | KR#1,491/2,436 Sec#165/234 |
| Revenue | 143.52B KRW | KR#1,183/2,436 Sec#72/234 |
| Net Income | 9.47B KRW | KR#923/2,436 Sec#59/234 |
| Total Assets | 207.28B KRW | KR#1,252/2,436 Sec#94/234 |
| Net Assets | 142.56B KRW | KR#1,141/2,436 Sec#85/234 |
| Employees | 257 | KR#903/2,436 Sec#76/234 |
| Value | ||
| P/E | 7.09x | KR#503/2,436 Sec#22/234 |
| P/B | 0.47x | KR#773/2,436 Sec#30/234 |
| PEG | 0.61x | KR#700/2,436 Sec#43/234 |
| P/S | 0.47x | KR#906/2,436 Sec#38/234 |
| EV/EBITDA | 5.82x | KR#297/2,436 Sec#8/234 |
| FCF Yield | 11.36% | KR#589/2,436 Sec#21/234 |
| Profitability | ||
| ROE | 6.64% | KR#832/2,436 Sec#62/234 |
| ROA | 4.57% | KR#704/2,436 Sec#55/234 |
| Op. Margin | 7.95% | KR#631/2,436 Sec#56/234 |
| Revenue Growth | 8.01% | KR#1,025/2,436 Sec#94/234 |
| Earnings Growth | 11.67% | KR#821/2,436 Sec#54/234 |
| Financial Health | ||
| Debt Ratio | 145.40% | KR#1,127/2,436 Sec#129/234 |
| Total Debt | 25.26B KRW | KR#1,273/2,436 Sec#102/234 |
| FCF | 7.62B KRW | KR#788/2,436 Sec#47/234 |
| Cash | 26.04B KRW | KR#1,084/2,436 Sec#74/234 |
| Current Ratio | 1.68x | KR#1,170/2,436 Sec#128/234 |
| Net Debt/EBITDA | -0.07x | KR#673/2,436 Sec#42/234 |
| Dividend | ||
| Div. Yield | 3.21% | KR#611/2,436 Sec#27/234 |
| Div. Growth | 15.00% | KR#495/2,436 Sec#27/234 |
| Performance | ||
| 1Y Return | -17.12% | KR#1,139/2,436 Sec#87/234 |
| 1M Return | -4.60% | KR#1,141/2,436 Sec#102/234 |
| From 52W High | -28.82% | KR#362/2,436 Sec#24/234 |
| 1Y MDD | -27.53% | KR#153/2,436 Sec#7/234 |
| Trading | ||
| Volume | 42,518 shares | KR#1,516/2,436 Sec#141/234 |
| Foreign Own. | 2.19% | KR—/2,436 Sec—/234 |
| Per Share | ||
| EPS | 461 KRW | KR#939/2,436 Sec#65/234 |
| BPS | 7,146 KRW | KR#1,171/2,436 Sec#83/234 |
Company Info
Established in 1941 as Yuhan Trading and listed on the securities market in 1975, the company is a pharmaceutical firm manufacturing and selling pharmaceuticals and health functional foods from its plant in Jecheon, Chungcheongbuk-do. It supplies specialized pharmaceuticals to domestic hospitals and clinics, operates a contract manufacturing business, and exports finished pharmaceuticals to various countries. With subsidiaries including YUYU Healthcare, YUYU Medicals, and YUYU VENTURES, the company is diversifying its business, including expansion into animal pharmaceuticals. The company is headquartered in Jecheon, Chungcheongbuk-do.